BNP Paribas Buys 1,762 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

BNP Paribas boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,727 shares of the medical equipment provider’s stock after purchasing an additional 1,762 shares during the quarter. BNP Paribas’ holdings in Intuitive Surgical were worth $12,908,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Principal Financial Group Inc. grew its holdings in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares during the last quarter. World Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical in the third quarter worth $228,000. Synovus Financial Corp grew its stake in shares of Intuitive Surgical by 1.1% in the third quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider’s stock worth $1,264,000 after acquiring an additional 28 shares during the last quarter. Nordea Investment Management AB increased its position in Intuitive Surgical by 31.7% during the fourth quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock worth $22,632,000 after acquiring an additional 10,405 shares during the period. Finally, Capital Market Strategies LLC raised its stake in Intuitive Surgical by 7.8% during the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider’s stock valued at $646,000 after purchasing an additional 90 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.4 %

NASDAQ:ISRG opened at $529.42 on Friday. The stock has a market capitalization of $189.75 billion, a P/E ratio of 82.59, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1 year low of $379.67 and a 1 year high of $616.00. The firm has a 50 day moving average of $504.32 and a 200-day moving average of $533.96.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm earned $1.50 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on ISRG shares. Piper Sandler dropped their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Barclays lowered their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock worth $17,229,143 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.